188 related articles for article (PubMed ID: 17938264)
1. DNA sequence selective adenine alkylation, mechanism of adduct repair, and in vivo antitumor activity of the novel achiral seco-amino-cyclopropylbenz[e]indolone analogue of duocarmycin AS-I-145.
Kiakos K; Sato A; Asao T; McHugh PJ; Lee M; Hartley JA
Mol Cancer Ther; 2007 Oct; 6(10):2708-18. PubMed ID: 17938264
[TBL] [Abstract][Full Text] [Related]
2. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
[TBL] [Abstract][Full Text] [Related]
3. A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065.
Sato A; McNulty L; Cox K; Kim S; Scott A; Daniell K; Summerville K; Price C; Hudson S; Kiakos K; Hartley JA; Asao T; Lee M
J Med Chem; 2005 Jun; 48(11):3903-18. PubMed ID: 15916443
[TBL] [Abstract][Full Text] [Related]
4. Novel furano analogues of duocarmycin C1 and C2: design, synthesis, and biological evaluation of seco-iso-cyclopropylfurano[2,3-e]indoline (seco-iso-CFI) and seco-cyclopropyltetrahydrofurano[2,3-f]quinoline (seco-CFQ) analogues.
Howard TT; Lingerfelt BM; Purnell BL; Scott AE; Price CA; Townes HM; McNulty L; Handl HL; Summerville K; Hudson SJ; Bowen JP; Kiakos K; Hartley JA; Lee M
Bioorg Med Chem; 2002 Sep; 10(9):2941-52. PubMed ID: 12110316
[TBL] [Abstract][Full Text] [Related]
5. Alteration in the choice of DNA repair pathway with increasing sequence selective DNA alkylation in the minor groove.
Brooks N; McHugh PJ; Lee M; Hartley JA
Chem Biol; 2000 Sep; 7(9):659-68. PubMed ID: 10980446
[TBL] [Abstract][Full Text] [Related]
6. Excision repair of adozelesin-N3 adenine adduct by 3-methyladenine-DNA glycosylases and UvrABC nuclease.
Jin SG; Choi JH; Ahn B; O'Connor TR; Mar W; Lee CS
Mol Cells; 2001 Feb; 11(1):41-7. PubMed ID: 11266119
[TBL] [Abstract][Full Text] [Related]
7. A Short Review on the Synthetic Strategies of Duocarmycin Analogs that are Powerful DNA Alkylating Agents.
Patil PC; Satam V; Lee M
Anticancer Agents Med Chem; 2015; 15(5):616-30. PubMed ID: 25511515
[TBL] [Abstract][Full Text] [Related]
8. A novel achiral seco-cyclopropylpyrido[e]indolone (CPyI) analog of CC-1065 and the duocarmycins: synthesis, DNA interactions, in vivo anticancer and anti-parasitic evaluation.
Chavda S; Babu B; Yanow SK; Jardim A; Spithill TW; Kiakos K; Kluza J; Hartley JA; Lee M
Bioorg Med Chem; 2010 Jul; 18(14):5016-24. PubMed ID: 20579889
[TBL] [Abstract][Full Text] [Related]
9. Sequence-selective guanine reactivity by duocarmycin A.
Mitchell MA; Weiland KL; Aristoff PA; Johnson PD; Dooley TP
Chem Res Toxicol; 1993; 6(4):421-4. PubMed ID: 8374036
[TBL] [Abstract][Full Text] [Related]
10. A novel achiral seco-amino-cyclopropylindoline (CI) analog of CC-1065 and the duocarmycins: design, synthesis and biological studies.
Toth JL; Trzupek JD; Flores LV; Kiakos K; Hartley JA; Pennington WT; Lee M
Med Chem; 2005 Jan; 1(1):13-9. PubMed ID: 16789881
[TBL] [Abstract][Full Text] [Related]
11. Nitro-chloromethylbenzindolines: hypoxia-activated prodrugs of potent adenine N3 DNA minor groove alkylators.
Wilson WR; Stribbling SM; Pruijn FB; Syddall SP; Patterson AV; Liyanage HD; Smith E; Botting KJ; Tercel M
Mol Cancer Ther; 2009 Oct; 8(10):2903-13. PubMed ID: 19808982
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric total synthesis of (+)- and ent-(-)-yatakemycin and duocarmycin SA: evaluation of yatakemycin key partial structures and its unnatural enantiomer.
Tichenor MS; Trzupek JD; Kastrinsky DB; Shiga F; Hwang I; Boger DL
J Am Chem Soc; 2006 Dec; 128(49):15683-96. PubMed ID: 17147378
[TBL] [Abstract][Full Text] [Related]
13. A Novel Depurination Methodology to Assess DNA Alkylation of Chloro-Bis-Seco-Cyclopropylbenzoindoles Allowed for Comparison of Minor-Groove Reactivity.
Wang S; Chen B; Dragovich P; Pillow T; Staben L; Guo J; Su D; Zhang C; Bobba S; Ma Y; Wang J; Sangaraju D; Wei B; Phillips GL; Khojasteh C; Zhang D
Drug Metab Dispos; 2019 May; 47(5):547-555. PubMed ID: 30858239
[TBL] [Abstract][Full Text] [Related]
14. Substituent effects within the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065.
Boger DL; Stauffer F; Hedrick MP
Bioorg Med Chem Lett; 2001 Aug; 11(15):2021-4. PubMed ID: 11454471
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of achiral analogs of duocarmycin SA.
Daniell K; Stewart M; Madsen E; Le M; Handl H; Brooks N; Kiakos K; Hartley JA; Lee M
Bioorg Med Chem Lett; 2005 Jan; 15(1):177-80. PubMed ID: 15582435
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders.
Baraldi PG; Balboni G; Pavani MG; Spalluto G; Tabrizi MA; Clercq ED; Balzarini J; Bando T; Sugiyama H; Romagnoli R
J Med Chem; 2001 Aug; 44(16):2536-43. PubMed ID: 11472207
[TBL] [Abstract][Full Text] [Related]
17. Toxicity and repair of DNA adducts produced by the natural product yatakemycin.
Mullins EA; Shi R; Eichman BF
Nat Chem Biol; 2017 Sep; 13(9):1002-1008. PubMed ID: 28759018
[TBL] [Abstract][Full Text] [Related]
18. CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents.
Boger DL; Johnson DS
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3642-9. PubMed ID: 7731958
[TBL] [Abstract][Full Text] [Related]
19. Specific alkylation of human telomere repeat sequences by a tandem-hairpin motif of pyrrole-imidazole polyamides with indole-seco-CBI.
Yamamoto M; Bando T; Kawamoto Y; Taylor RD; Hashiya K; Sugiyama H
Bioconjug Chem; 2014 Mar; 25(3):552-9. PubMed ID: 24490687
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of duocarmycin SA analogs incorporating the methyl 1,2,8,8a-tetrahydrocyclopropa[c]oxazolo[2,3-e]indol-4-one-6-carboxylate (COI) alkylation subunit.
Boyle KE; MacMillan KS; Ellis DA; Lajiness JP; Robertson WM; Boger DL
Bioorg Med Chem Lett; 2010 Mar; 20(6):1854-7. PubMed ID: 20171886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
